Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Registry Results See Less PVL, Pacemakers With Acurate neo2

Shelley Wood

November 29, 2022

Presentation TCT 2022

TCT 674: Implantation of TAVR with Corevalve in patient with lipodystrophy and severe aortic regurgitation.

Presenter: Prasanthi Yelavarthy

September 17, 2022

Presentation TCT 2022

TCT 770: S3 Ultra can be used to anchor the CoreValve in ventricular migration during transcatheter aortic valve replacement in pure aortic insufficiency

Presenter: Sanskriti Shrivastava

September 17, 2022

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Daily News

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Todd Neale

March 16, 2022

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Advertisement

Registry Results See Less PVL, Pacemakers With Acurate neo2

TCT 674: Implantation of TAVR with Corevalve in patient with lipodystrophy and severe aortic regurgitation.

TCT 770: S3 Ultra can be used to anchor the CoreValve in ventricular migration during transcatheter aortic valve replacement in pure aortic insufficiency

Early LV Recovery After TAVI Points to Better 5-Year Survival

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content